This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lijnen, H.R. Articles by Collen, D. Search for Related Content PubMed PubMed Citation Articles by Lijnen, H.R. Articles by Collen, D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Obesity Related Collections Obesity Animal models of human disease Risk Factors Cell biology/structural biology Valvular heart disease

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:374.)
© 2002 American Heart Association, Inc.

Vascular Biology

Matrix Metalloproteinase Inhibition Impairs Adipose Tissue Development in Mice

H.R. Lijnen; E. Maquoi; L.B. Hansen; B. Van Hoef; L. Frederix; D. Collen

From the Center for Molecular and Vascular Biology (H.R.L., E.M., B.V.H., L.F., D.C.), University of Leuven, Leuven, Belgium, and Finsen Laboratory (L.B.H.), Copenhagen, Denmark.

Correspondence to H.R. Lijnen, Center for Molecular and Vascular Biology, University of Leuven, Campus Gasthuisberg, O & N, Herestraat 49, B-3000 Leuven, Belgium. E-mail roger.lijnen{at}med.kuleuven.ac.be

The effect of galardin, a broad-spectrum matrix metalloproteinase (MMP) inhibitor, was studied in mice kept on a high fat diet (HFD). Five-week-old male wild-type mice were fed the HFD (42% fat) for up to 12 weeks and were daily injected intraperitoneally with the inhibitor (100 mg/kg) or with vehicle. After 12 weeks of the HFD, the body weights of both groups were comparable, but the weight of the isolated subcutaneous (SC) or gonadal (GON) fat deposits was significantly lower in the inhibitor-treated group than in the control group (88±11 versus 251±66 mg, respectively, for SC fat [P<0.05]; 90±24 versus 217±30 mg, respectively, for GON fat [P<0.02]). The number of adipocytes was somewhat higher and the diameter was somewhat smaller (but not significantly) in adipose tissues of the inhibitor-treated group. Adipose tissue of the inhibitor-treated mice contained more collagen than did that of the vehicle-treated mice (Sirius red–stained area of 42±2.6% versus 22±4.4%, respectively, for SC fat [P<0.05]; 21±5.1% versus 4.7±0.92%, respectively, for GON fat [P<0.01]); a distinct collagen-rich cap was formed around the inhibitor-treated tissue. In situ zymography with casein- or gelatin-containing gels confirmed a reduced MMP activity in SC and GON adipose tissues of inhibitor-treated mice. Thus, in this model, growth and development of adipose tissue appears to be limited by the formation of a collagen-rich matrix cap around the inhibitor-treated tissue. These data suggest a functional role for MMPs in the development of adipose tissue.

Key Words: matrix metalloproteinases • obesity • galardin • adipose tissue • adipocytes

This article has been cited by other articles:

				I. Gerin, G. W. Louis, X. Zhang, T. C. Prestwich, T. R. Kumar, M. G. Myers Jr., O. A. MacDougald, and W. B. Nothnick Hyperphagia and Obesity in Female Mice Lacking Tissue Inhibitor of Metalloproteinase-1 Endocrinology, April 1, 2009; 150(4): 1697 - 1704. [Abstract] [Full Text] [PDF]

				Y. Wu and C. M. Smas Wdnm1-like, a new adipokine with a role in MMP-2 activation Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E205 - E215. [Abstract] [Full Text] [PDF]

				H. R. Lijnen Angiogenesis and obesity Cardiovasc Res, May 1, 2008; 78(2): 286 - 293. [Abstract] [Full Text] [PDF]

				J. Gomez-Ambrosi, V. Catalan, B. Ramirez, A. Rodriguez, I. Colina, C. Silva, F. Rotellar, C. Mugueta, M. J. Gil, J. A. Cienfuegos, et al. Plasma Osteopontin Levels and Expression in Adipose Tissue Are Increased in Obesity J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3719 - 3727. [Abstract] [Full Text] [PDF]

				N. E. Hubbard, D. Lim, and K. L. Erickson Conjugated Linoleic Acid Alters Matrix Metalloproteinases of Metastatic Mouse Mammary Tumor Cells J. Nutr., June 1, 2007; 137(6): 1423 - 1429. [Abstract] [Full Text] [PDF]

				S. Kralisch, M. Bluher, A. Tonjes, U. Lossner, R. Paschke, M. Stumvoll, and M. Fasshauer Tissue inhibitor of metalloproteinase-1 predicts adiposity in humans Eur. J. Endocrinol., February 1, 2007; 156(2): 257 - 261. [Abstract] [Full Text] [PDF]

				S Kralisch, U Lossner, M Bluher, R Paschke, M Stumvoll, and M Fasshauer Tissue inhibitor of metalloproteinase 1 expression and secretion are induced by {beta}-adrenergic stimulation in 3T3-L1 adipocytes. J. Endocrinol., June 1, 2006; 189(3): 665 - 670. [Abstract] [Full Text] [PDF]

				J. G. Granneman, P. Li, Z. Zhu, and Y. Lu Metabolic and cellular plasticity in white adipose tissue I: effects of {beta}3-adrenergic receptor activation Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E608 - E616. [Abstract] [Full Text] [PDF]

				V. Bourlier, A. Zakaroff-Girard, S. De Barros, C. Pizzacalla, V. D. de Saint Front, M. Lafontan, A. Bouloumie, and J. Galitzky Protease Inhibitor Treatments Reveal Specific Involvement of Matrix Metalloproteinase-9 in Human Adipocyte Differentiation J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1272 - 1279. [Abstract] [Full Text] [PDF]

				A. M. Pendas, A. R. Folgueras, E. Llano, J. Caterina, F. Frerard, F. Rodriguez, A. Astudillo, A. Noel, H. Birkedal-Hansen, and C. Lopez-Otin Diet-Induced Obesity and Reduced Skin Cancer Susceptibility in Matrix Metalloproteinase 19-Deficient Mice Mol. Cell. Biol., June 15, 2004; 24(12): 5304 - 5313. [Abstract] [Full Text] [PDF]

				H. S. Randeva, K. C. Lewandowski, J. Komorowski, R. D. Murray, C. J. O'Callaghan, E. W. Hillhouse, H. Stepien, and S. M. Shalet Growth Hormone Replacement Decreases Plasma Levels of Matrix Metalloproteinases (2 and 9) and Vascular Endothelial Growth Factor in Growth Hormone-Deficient Individuals Circulation, May 25, 2004; 109(20): 2405 - 2410. [Abstract] [Full Text] [PDF]

				G. J. Hausman and R. L. Richardson Adipose tissue angiogenesis J Anim Sci, March 1, 2004; 82(3): 925 - 934. [Abstract] [Full Text] [PDF]

				E. H. Sage, M. Reed, S. E. Funk, T. Truong, M. Steadele, P. Puolakkainen, D. H. Maurice, and J. A. Bassuk Cleavage of the Matricellular Protein SPARC by Matrix Metalloproteinase 3 Produces Polypeptides That Influence Angiogenesis J. Biol. Chem., September 26, 2003; 278(39): 37849 - 37857. [Abstract] [Full Text] [PDF]

				A. D. Bradshaw, D. C. Graves, K. Motamed, and E. H. Sage SPARC-null mice exhibit increased adiposity without significant differences in overall body weight PNAS, May 13, 2003; 100(10): 6045 - 6050. [Abstract] [Full Text] [PDF]

				C. Chavey, B. Mari, M.-N. Monthouel, S. Bonnafous, P. Anglard, E. Van Obberghen, and S. Tartare-Deckert Matrix Metalloproteinases Are Differentially Expressed in Adipose Tissue during Obesity and Modulate Adipocyte Differentiation J. Biol. Chem., March 28, 2003; 278(14): 11888 - 11896. [Abstract] [Full Text] [PDF]